Other diseasesReferences:


"The fire brigade repeatedly re-use the same fire engines, and disease control administrators can repeatedly re-use the same control measures. If a model examines an epidemic and comes up with with a radical new solution, then the alarm bells begin to ring. Those same alarm bells call for a re-examination of the biology rather than more complex mathematics."

Re-examination of the biology often provides a fascinating (and unseen) outcome, upon which some accurate and simple biomodels can be built; moreover, any contingency plans for disease control should be formed during the time periods between epidemics [18]. Many infectious diseases (both viral and bacterial) exhibit similar epidemiological characteristics that will build accurate biomodels, and these can determine how, when and where a disease will spread. Some diseases are of significant economic importance such as BSE and Foot-and-Mouth Disease. Other transboundary and emerging diseases hold significance for both animals and people alike, or hold the potential for creating worldwide pandemics, such as SARS, Avian Flu, Swine Flu, etc. All of these diseases exhibit subclinical and acute forms.

The disease ratio (DR) of subclinical to acute forms of a disease, is equally relevant for diseases with short incubation periods and rapid transmission rates (such as Foot-and-Mouth Disease), as it is for a disease with a longer incubation period and a slower transmission rate (such as Tuberculosis). The DR for FMD has been measured at 1:1, whilst the DR for TB has been measured at 3:1. All diseases with a measurable DR can benefit from the application of biomodels. Biomodels can be used to answer relevant questions such as the possible success of a badger cull in reducing the UK TB prevalence ie. it is currently 600% higher than other EU countries and grew by 20% over the past decade. Biomodels can be applied to a large number of economically important diseases, offering a set of predictive capabilities that conventional disease tracking measures cannot provide. Biomodels can be applied to all diseases that exhibit subclinical disease. Most infectious diseases exhibit subclinical forms.